Rajthanee Hospital PCL (BKK:RJH)

Rajthanee Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,642	2,739	2,348	3,365	3,118	1,855
Other Revenue	30.69	26.09	27.54	26.15	24.28	21.97
Revenue	2,673	2,765	2,375	3,392	3,142	1,877
Revenue Growth (YoY)	-3.42%	16.39%	-29.96%	7.94%	67.35%	4.40%
Cost of Revenue	2,057	1,897	1,618	1,848	1,684	1,271
Gross Profit	616.1	867.42	757.68	1,544	1,458	606.52
Selling, General & Admin	333.33	345.18	222.43	244.95	183.46	153.93
Operating Expenses	333.33	345.18	222.43	244.95	183.46	153.93
Operating Income	282.77	522.25	535.25	1,299	1,274	452.59
Interest Expense	-58.86	-52.67	-33.54	-24.48	-5.92	-0.26
Interest & Investment Income	4.82	10.89	17.24	15.04	2.81	0.93
EBT Excluding Unusual Items	228.73	480.47	518.94	1,289	1,271	453.26
Pretax Income	228.73	480.47	518.94	1,289	1,271	453.26
Income Tax Expense	-8.32	-1.95	103.24	255.8	254.92	39.64
Earnings From Continuing Operations	237.06	482.42	415.7	1,034	1,016	413.62
Minority Interest in Earnings	15.52	10.62	3.97	-4.45	-4.36	-1.13
Net Income	252.58	493.04	419.67	1,029	1,012	412.49
Net Income to Common	252.58	493.04	419.67	1,029	1,012	412.49
Net Income Growth	-53.82%	17.48%	-59.22%	1.71%	145.33%	4.20%
Shares Outstanding (Basic)	294	299	299	299	300	300
Shares Outstanding (Diluted)	294	299	299	299	300	300
Shares Change (YoY)	-1.70%	-0.17%	0.06%	-0.25%	-0.02%	-
EPS (Basic)	0.86	1.65	1.40	3.44	3.37	1.37
EPS (Diluted)	0.86	1.65	1.40	3.44	3.37	1.37
EPS Growth	-53.02%	17.68%	-59.25%	1.96%	145.38%	4.20%
Free Cash Flow	295.4	-77.99	190.74	571.54	527.23	189.62
Free Cash Flow Per Share	1.00	-0.26	0.64	1.91	1.76	0.63
Dividend Per Share	0.200	0.700	1.200	2.500	2.700	1.000
Dividend Growth	-73.33%	-41.67%	-52.00%	-7.41%	170.00%	-9.09%
Gross Margin	23.05%	31.37%	31.90%	45.52%	46.40%	32.30%
Operating Margin	10.58%	18.89%	22.53%	38.30%	40.56%	24.11%
Profit Margin	9.45%	17.83%	17.67%	30.35%	32.21%	21.97%
Free Cash Flow Margin	11.05%	-2.82%	8.03%	16.85%	16.78%	10.10%
EBITDA	466.96	678.2	680.72	1,463	1,434	558.35
EBITDA Margin	17.47%	24.53%	28.66%	43.12%	45.63%	29.74%
D&A For EBITDA	184.19	155.96	145.47	163.59	159.33	105.75
EBIT	282.77	522.25	535.25	1,299	1,274	452.59
EBIT Margin	10.58%	18.89%	22.53%	38.30%	40.56%	24.11%
Effective Tax Rate	-	-	19.89%	19.84%	20.05%	8.75%
Revenue as Reported	2,678	2,776	2,393	3,407	3,145	1,878

Source: S&P Global Market Intelligence. Standard template. Financial Sources.